| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 08/09/2006 | EP1032393B1 Quinoline-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 08/09/2006 | EP0988301B1 Imidazolyl-cyclic acetals |
| 08/09/2006 | CN1816536A Regulator of cannabinoid receptor |
| 08/09/2006 | CN1816531A Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 08/09/2006 | CN1816529A Pyrazole-amide compounds useful as kinase inhibitors |
| 08/09/2006 | CN1814596A Muscarinic agonists |
| 08/09/2006 | CN1268614C Substituted pyrazolyl benzsulfamide compound for curing inflammation |
| 08/09/2006 | CN1268333C Indolinone compounds for the treatment of disease |
| 08/08/2006 | US7087768 6-O-(4-methoxyaniline)acetyl fumagillol for example; superior angiogenesis inhibitory effect with less toxicity, also a cancer metastasis inhibitor, and treats angiogenesis related disorders such as other various inflammatory diseases such as rheumatic disease, psoriasis, and diabetic retinopathy |
| 08/08/2006 | US7087638 Plant safening agents; |
| 08/08/2006 | US7087635 3-substituted oxindole β3 agonists |
| 08/08/2006 | US7087631 Aryltetrazole compounds, and compositions thereof |
| 08/08/2006 | US7087626 TGF-beta signal transduction inhibitors |
| 08/08/2006 | US7087625 N-substituted aniline and diphenylamine analogs |
| 08/08/2006 | US7087624 Substituted pyrazole compounds |
| 08/08/2006 | US7087622 Pyridone compounds as inhibitors of bacterial type III protein secreation systems |
| 08/08/2006 | US7087605 5-Ethyl-imidazotriazinones |
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
| 08/08/2006 | US7087600 Anticancer agents; side effect reduction |
| 08/08/2006 | US7087597 Pyrimidine 5-carboxamide compounds, process for producing the same and use thereof |
| 08/08/2006 | US7087594 Alkyl ether derivatives or salts thereof |
| 08/08/2006 | CA2282183C Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines |
| 08/08/2006 | CA2253429C 2,4-diaminopyrimidine derivates as dopamine d4 receptor antagonists |
| 08/08/2006 | CA2188835C Novel compounds and methods for synthesis and therapy |
| 08/03/2006 | WO2006081337A2 Erastin analogues and their uses for killing cancer cells |
| 08/03/2006 | WO2006080577A1 Indole derivatives |
| 08/03/2006 | WO2006080574A1 1,3-dihydro-2h-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle |
| 08/03/2006 | WO2006080450A1 Igf-1r inhibitor |
| 08/03/2006 | WO2006079610A1 Nitrooxy sartan derivatives as angiotensin ii receptor blockers for the treatment of cardiovascular and inflammatory diseases |
| 08/03/2006 | WO2006065480A3 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 08/03/2006 | WO2006055708A3 Heterocycle substituted carboxylic acids for the treatment of diabetes |
| 08/03/2006 | US20060173189 Synthesis of himbacine analogs |
| 08/03/2006 | US20060173188 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 08/03/2006 | US20060173061 New beta-agonists, processes for preparing them and their use as pharmaceutical compositions |
| 08/03/2006 | US20060173055 Pyrrole compounds useful as kinase inhibitors |
| 08/03/2006 | US20060173040 bactericide; derivatives of pseudopeptide Andrimid in which beta-phenylalanine amide is replaced by heteroaromatic or substituted aromatic amide; N-{(1S)-3-[((1S)-1-{[(3R,4S)-1,4-Dimethyl-2,5-dioxo-3-pyrrolidinyl]carbonyl}-2-methylpropyl)amino]-3-oxo-1-phenylpropyl}-2-pyridinecarboxamide; antibiotics |
| 08/03/2006 | US20060173028 Therapeutic and/or preventive agent for chronic skin disease |
| 08/03/2006 | US20060173027 Spirocvclic piperidines as mch1 antagonists and uses thereof |
| 08/03/2006 | US20060173022 Heterocyclic amides, method for the production thereof, substances containing said heterocyclic amides, and use thereof as pesticides |
| 08/03/2006 | US20060173010 Modulators of TNF-alpha signaling |
| 08/03/2006 | US20060173003 4-Heteroarylamino-7-H(hetero)aryl-substituted, e.g., [6-(propane-2-sulfonyl)-pyridin-3-yl]-[7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl ]-amine hydrochloride; the compounds inhibit binding of vanilloid ligands to capsaicin receptors and are used to treat neuropathic pain |
| 08/03/2006 | US20060172999 2-[(1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-phenyl-tetrahydropyran-4-yl]methyl-2-oxa-8-aza-spiro[4,5]decan-4-ol; neurokinin 1 (NK-1) receptor antagonists; antidepressant, anxiolytic, analgesic, antiinflammatory agent; migraine, emesis or postherpetic neuralgia |
| 08/03/2006 | US20060172984 Methods and compositions of novel triazine compounds |
| 08/03/2006 | US20060172936 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections |
| 08/03/2006 | US20060172358 Novel chemiluminescent compounds and their use |
| 08/03/2006 | DE10132725A1 Substituierte γ-Lactonverbindungen Substituted γ-lactone |
| 08/03/2006 | CA2596527A1 Igf-1r inhibitors |
| 08/03/2006 | CA2595855A1 Pyrazine compounds for inflammation and immune-related uses |
| 08/03/2006 | CA2595848A1 Erastin and erastin binding proteins, and uses thereof |
| 08/03/2006 | CA2595218A1 Indole derivatives having inhibitory activity against sodium-dependent glucose transporter |
| 08/02/2006 | EP1686127A1 New heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases |
| 08/02/2006 | EP1686120A2 Methods and compositions utilizing quinazolinones |
| 08/02/2006 | EP1685127A1 Heterocyclyl-substituted oxetanes for the treatment of proliferative or infectious diseases |
| 08/02/2006 | EP1685116A1 Quinazoline derivatives |
| 08/02/2006 | EP1685113A1 Substituted pyrazoles as ppar agonists |
| 08/02/2006 | EP1685111A1 Substituted nicotinoylcarbamates as pesticides |
| 08/02/2006 | EP1685109A2 Amide compounds as ion channel ligands and uses thereof |
| 08/02/2006 | EP1685108A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 08/02/2006 | EP1685107A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 08/02/2006 | EP1685102A1 Melanocortin receptor agonists |
| 08/02/2006 | EP1685101A1 N-acylated-3-(benzoyl)-pyrrolidines as 11-beta-hsd1 inhibitors useful for the treatment of metabolic disorders. |
| 08/02/2006 | EP1685090A1 Androgen receptor modulators |
| 08/02/2006 | EP1684762A2 Urea derivatives as kinase modulators |
| 08/02/2006 | EP1684757A1 Substituted piperidines for the treatment of metabolic syndrome |
| 08/02/2006 | EP1684745A2 Hepatitis c virus inhibitors |
| 08/02/2006 | EP1073637B1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases |
| 08/02/2006 | EP0986551B1 Sulfonamide derivatives, their production and use |
| 08/02/2006 | CN1812984A Benzofuranyl-and benzothienyl-piperazinyl quinolines as 5-serotonin reuptake inhibitors |
| 08/02/2006 | CN1812983A Substituted pyrrole derivatives and their use as hmg-co inhibitors |
| 08/02/2006 | CN1812981A Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 08/02/2006 | CN1812979A Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 08/02/2006 | CN1812977A Substituted carboxylic acids |
| 08/02/2006 | CN1812974A N-{'4-substituted piperazine-1-sulfonylmethyl]alkyl}-N-hydroxyformamide compounds as metalloproteinase inhibitors |
| 08/02/2006 | CN1812973A Indazole compounds useful as protein kinase inhibitors |
| 08/02/2006 | CN1812972A Caspase inhibitors and uses thereof |
| 08/02/2006 | CN1812956A Biaryloxymethylarenecarboxylic acids as glycogen synthase activator |
| 08/02/2006 | CN1812812A Serum cholesterol lowering agnet or preventive or therapeutic agent for atherosclerosis |
| 08/02/2006 | CN1812785A New effector conjugates, process for their production and their pharmaceutical use |
| 08/02/2006 | CN1267430C Triazole compounds with dopamine -D3-receptor affinity |
| 08/02/2006 | CN1267424C Piperazinylpyrazine compounds as agonist or antagonist of 5-hydroxytryptamine 5HT-2 receptor |
| 08/02/2006 | CN1267423C Substituted 2-phenylaminomidazoline phenyl ketone derivatives as IP antagonists |
| 08/02/2006 | CN1267419C Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides |
| 08/01/2006 | US7084282 Process for preparing 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
| 08/01/2006 | US7084168 Indoline derivatives |
| 08/01/2006 | US7084166 Such as 1,1-di-(N-benzyl-indol-3-yl)-1-butene; for drug resistant tumors |
| 08/01/2006 | US7084164 Triazole derivative |
| 08/01/2006 | US7084156 2-Aminoquinoline compounds |
| 08/01/2006 | US7084155 Chemokine receptor binding heterocyclic compounds |
| 08/01/2006 | US7084148 Analgesics; antipyretics; antiinflammatory agents |
| 08/01/2006 | US7084147 Anilinoquinazaolines as protein tyrosine kinase inhibitors |
| 08/01/2006 | US7084145 Triazole compounds useful in therapy |
| 08/01/2006 | US7084144 Sulfonyl group containing compounds and their use for the treatment of erectile dysfunction |
| 08/01/2006 | US7084142 Anticoagulants; 2-[1S-(4-(ethoxycarbonyl)piperazin-1-yl)carbonyl-3-carboxypropyl]aminocarbonyl-4-(2-methylthiazol-4-yl)methoxyquinoline; antithrombotic agents in the treatment and prevention of thrombosis |
| 08/01/2006 | US7084141 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 08/01/2006 | US7084139 Cardiovascular disorders; anticoagulants; antitumor, anticancer agents; Alzheimer's disease; Parkinson's disease |
| 08/01/2006 | US7084108 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 08/01/2006 | CA2341263C Enzyme inhibition immunoassay |
| 08/01/2006 | CA2276945C Tricyclic-substituted pyrazolyl benzenesulfonamides and pharmaceutical compositions thereof |
| 08/01/2006 | CA2236851C Substituted vinylpyridine derivatives and drugs containing the same |
| 08/01/2006 | CA2189456C Substituted aromatic thiocarboxylic acid amides and their use as herbicides |